Work

Modulation of enhancer of zeste homolog 2 (EZH2) pharmacodynamic markers and tumour gene expression by mevrometostat in combination with enzalutamide in patients with castration-resistant prostate cancer (CRPC)

Year: 2025

Type: article

Source: European Urology Open Science

DOI: 10.1016/s2666-1683(25)01615-5

Authors: M.T. Schweizer, L. Liu, S-Y. Tang, W. Roh, V. Bonato, J. Carles, B. Garmezy, C.J. Dunshee, G. De Velasco, K. Penkov, C. Andreu-Vieyra, N. Soman, B. Mellado

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $1,800

OpenAlex ID: W4416187973

FWCI:

Cites:

Cited by:

Related to: